The Missing Link in Medical AI: Why the EU Needs a Framework for Model Sharing

The European Union is making a massive move toward a digital-first healthcare future. Through the European Health Data Space (EHDS), the EU is establishing a robust framework for health data governance, specifically positioning artificial intelligence (AI) innovation as a central strategic goal. While the EHDS successfully enables cross-border access to vital health data, a critical gap remains that could undermine the very innovation it seeks to foster: the lack of access to the AI models themselves.

To truly unlock the potential of medical AI, the EU must move beyond simply sharing data and begin building mechanisms for sharing the models trained on that data.

The Promise and the Gap in the EHDS

The EHDS is designed to be a cornerstone of Europe’s AI-driven innovation strategy. By providing a comprehensive framework for health data governance, it allows for the seamless, cross-border movement of data that is essential for training sophisticated medical algorithms. This access is intended to fuel breakthroughs in diagnostics, personalized medicine and public health monitoring.

However, there is a fundamental disconnect in the current regulatory approach. While the EHDS creates pathways for researchers and developers to access high-quality health datasets, it doesn’t provide comparable access to the AI models that have been developed using those datasets. This creates a “silo” effect where data flows freely, but the resulting intelligence remains locked behind proprietary walls.

The Reproducibility Crisis in Medical AI

In the medical community, reproducibility is the gold standard. For an AI tool to be clinically useful, its results must be verifiable and consistent across different populations, and settings. The current lack of model-sharing mechanisms poses a significant threat to this scientific rigor.

Why Data Access Alone Isn’t Enough

Accessing the same dataset used to train a specific model is only half the battle. Without access to the model itself—including its architecture, weights, and training parameters—other researchers cannot truly replicate the results. This lack of transparency leads to several critical issues:

• Verification Hurdles: It is difficult to independently audit a model’s performance or identify potential biases if the model cannot be tested by third parties.
• Stagnant Innovation: Instead of building upon existing breakthroughs, developers are often forced to “reinvent the wheel,” wasting time and resources by training new models from scratch.
• Clinical Uncertainty: For healthcare providers, the inability to verify how a model arrived at a specific recommendation creates a barrier to trust and widespread clinical adoption.

A Path Forward: Supplementing the EHDS

To ensure that AI innovation in Europe is both useful and reproducible, the EU should supplement the EHDS regulation with a dedicated framework for AI model sharing. This framework wouldn’t necessarily require the total abandonment of intellectual property, but it would establish standardized protocols for sharing models for the purposes of scientific validation, safety auditing, and collaborative research.

By integrating model-sharing provisions into the broader health data strategy, the EU can move from a system that merely provides the “raw ingredients” (data) to one that facilitates the sharing of the “finished recipes” (AI models). This is the only way to ensure that the next generation of medical AI is transparent, reliable, and capable of transforming patient care across the continent.

Key Takeaways

• Strategic Goal: The EHDS aims to position AI innovation as a primary objective for the European Union.
• The Critical Gap: Current regulations focus on cross-border data access but lack mechanisms for sharing the AI models trained on that data.
• The Risk: Without model sharing, the medical community faces significant challenges regarding scientific reproducibility and model verification.
• The Solution: A dedicated framework for AI model sharing is needed to supplement the EHDS and ensure robust, transparent, and innovative medical AI.